Clover Health Investments Corp (CLOV) Q3 2024 Earnings Call Highlights: Strong Financial ... [Yahoo! Finance]
Clover Health Investments, Corp. - Class A Common stock (CLOV)
Company Research
Source: Yahoo! Finance
Adjusted EBITDA: Improved to a profit of $19 million for Q3 2024, up from $3 million in Q3 2023. Year-to-Date Adjusted EBITDA: Increased by $87 million year-over-year, reaching $62 million. Insurance Benefits Expense Ratio (BER): Improved to 82.8% in Q3 2024 from 82.3% in Q3 2023. Insurance Medical Cost Ratio (MCR): Improved to 78% in Q3 2024 from 78.5% in Q3 2023. Insurance Revenue: $323 million for Q3 2024, representing a 7% year-over-year growth. Year-to-Date Revenue: $1.14 billion, reflecting a 9% year-over-year growth. Total SG&A: Decreased by 11% year-over-year for Q3 2024. Adjusted SG&A: $62 million for Q3 2024, an 8% decrease year-over-year. Cash Flow from Operating Activities: $50 million for Q3 2024, with year-to-date cash flow at $130 million. Cash and Investments: $531 million at the end of Q3 2024, with $306 million at the parent entity level. Full Year 2024 Insurance Revenue Guidance: Reaffirmed between $1.35 billion and $1.375 billion. Full Year 2
Show less
Read more
Impact Snapshot
Event Time:
CLOV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLOV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLOV alerts
High impacting Clover Health Investments, Corp. - Class A Common stock news events
Weekly update
A roundup of the hottest topics
CLOV
News
- Clover Health to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Clover Health Investments, Corp. (NASDAQ: CLOV) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $6.00 price target on the stock.MarketBeat
- Bears are Losing Control Over Clover Health Investments (CLOV), Here's Why It's a 'Buy' Now [Yahoo! Finance]Yahoo! Finance
- Clover Health Investments Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]Yahoo! Finance
- CLOV Stock Declines Despite Q3 Earnings Beat, FY24 View Revised [Yahoo! Finance]Yahoo! Finance
CLOV
Earnings
- 11/6/24 - Beat
CLOV
Sec Filings
- 12/17/24 - Form 4
- 12/17/24 - Form 4
- 12/17/24 - Form 4
- CLOV's page on the SEC website